Gansu new bioequivalence (BE) clinical research base settled in the Second Provincial Hospital.

People's Network Lanzhou 65438+1October 6 (Mou Jian) On the 6th, the Second People's Hospital of Gansu Province held the launching ceremony of the BE/I clinical research base and the BE practical experience forum. It is reported that this is the first bioequivalence (BE) clinical research base newly built in Gansu after the new policy of national medical reform.

According to Mi Denghai, president of the Second People's Hospital of Gansu Province, the BE clinical research base in this hospital has a total area of 1.600 square meters and 45 beds. The base has beautiful environment, advanced facilities and reasonable planning, including hardware facilities such as clinical trial ward, laboratory, blood collection room and rescue room, and is equipped with functional rooms such as subjects' reception room, doctors' and nurses' offices and entertainment activities. The emergency center and ICU center of the hospital provide rescue support for the base at any time.

"The consistency evaluation of generic drug quality and efficacy is a major event that benefits the country and the people, and it is also a major decision and deployment at the national strategic level. As a veteran comprehensive top three hospital in Gansu health system, it is of great significance for the Second Hospital of Gansu Province to actively participate. " Jin Zhongjie, deputy director of Gansu Provincial Health Planning Commission, said at the launching ceremony.

Jin Zhongjie said: "A complete clinical trial of drugs requires both rigorous design and strict implementation. The data produced by clinical trials is the key basis to decide whether a drug can be approved for marketing. This puts forward higher requirements for the academic level and management level of drug clinical trial institutions. I hope that the Second Hospital of Gansu Province can firmly seize this opportunity, uphold a rigorous, enterprising and professional attitude, adhere to a scientific, objective and true spirit, actively explore, strictly abide by GCP norms and technical standards, and constantly improve the academic and management level, so as to improve the quality of generic drugs in China and the overall development level of the pharmaceutical industry, and make contributions to ensuring the safety and effectiveness of public medication. "